These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 32117025)

  • 1. A Patient With CAD Deficiency Responsive to Uridine and Literature Review.
    Zhou L; Xu H; Wang T; Wu Y
    Front Neurol; 2020; 11():64. PubMed ID: 32117025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAD mutations and uridine-responsive epileptic encephalopathy.
    Koch J; Mayr JA; Alhaddad B; Rauscher C; Bierau J; Kovacs-Nagy R; Coene KL; Bader I; Holzhacker M; Prokisch H; Venselaar H; Wevers RA; Distelmaier F; Polster T; Leiz S; Betzler C; Strom TM; Sperl W; Meitinger T; Wortmann SB; Haack TB
    Brain; 2017 Feb; 140(2):279-286. PubMed ID: 28007989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Report: Rapid Treatment of Uridine-Responsive Epileptic Encephalopathy Caused by CAD Deficiency.
    Zhou L; Deng J; Stenton SL; Zhou J; Li H; Chen C; Prokisch H; Fang F
    Front Pharmacol; 2020; 11():608737. PubMed ID: 33364968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical features of 6 children with uridine-responsive developmental epileptic encephalopathy 50 caused by CAD gene variants].
    Zhou L; Fang F; Deng J; Liu SJ; Chen CH; Li H; Ren CH; Wu Y
    Zhonghua Er Ke Za Zhi; 2023 May; 61(5):453-458. PubMed ID: 37096266
    [No Abstract]   [Full Text] [Related]  

  • 5. Generation of a human iPSC line BCHNCi001-A from a patient with uridine-responsive epileptic encephalopathy carrying biallelic CAD mutations.
    Zhou L; Xu H; Wu Y; Fang F
    Stem Cell Res; 2022 Dec; 65():102947. PubMed ID: 36283272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescent-onset epilepsy and deterioration associated with CAD deficiency: A case report.
    Silva S; Rosas M; Guerra B; Muñoz M; Fujita A; Sakamoto M; Matsumoto N
    Brain Dev; 2024 Aug; 46(7):250-253. PubMed ID: 38641466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the clinical and genetic spectrum of CAD deficiency: an epileptic encephalopathy treatable with uridine supplementation.
    Rymen D; Lindhout M; Spanou M; Ashrafzadeh F; Benkel I; Betzler C; Coubes C; Hartmann H; Kaplan JD; Ballhausen D; Koch J; Lotte J; Mohammadi MH; Rohrbach M; Dinopoulos A; Wermuth M; Willis D; Brugger K; Wevers RA; Boltshauser E; Bierau J; Mayr JA; Wortmann SB
    Genet Med; 2020 Oct; 22(10):1589-1597. PubMed ID: 32820246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uridine monophosphate (UMP)-responsive developmental and epileptic encephalopathy: A case report of two siblings and a review of literature.
    Al-Otaibi A; AlAyed A; Al Madhi A; Saeed L; Ng BG; Freeze HH; Almannai M
    Mol Genet Metab Rep; 2022 Mar; 30():100835. PubMed ID: 35242569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel CAD gene mutations in a boy with developmental and epileptic encephalopathy 50 with dramatic response to uridine therapy: a case report and a review of the literature.
    Duan L; Ye L; Yin R; Sun Y; Yu W; Zhang Y; Zhong H; Bao X; Tian X
    BMC Pediatr; 2024 Mar; 24(1):160. PubMed ID: 38454370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Treatable Genetic Disease Caused by CAD Mutation.
    Peng X; Xia LP; Zhang HJ; Zhang J; Yu SQ; Wang S; Xu YM; Yao B; Ye J
    Front Pediatr; 2022; 10():771374. PubMed ID: 35356445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biallelic hypomorphic variants in CAD cause uridine-responsive macrocytic anaemia with elevated haemoglobin-A2.
    Steinberg-Shemer O; Yacobovich J; Noy-Lotan S; Dgany O; Krasnov T; Barg A; Landau YE; Kneller K; Somech R; Gilad O; Brik Simon D; Orenstein N; Izraeli S; Del Caño-Ochoa F; Tamary H; Ramón-Maiques S
    Br J Haematol; 2024 Mar; 204(3):1067-1071. PubMed ID: 37984840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond genetics: Deciphering the impact of missense variants in CAD deficiency.
    Del Caño-Ochoa F; Ng BG; Rubio-Del-Campo A; Mahajan S; Wilson MP; Vilar M; Rymen D; Sánchez-Pintos P; Kenny J; Ley Martos M; Campos T; Wortmann SB; Freeze HH; Ramón-Maiques S
    J Inherit Metab Dis; 2023 Nov; 46(6):1170-1185. PubMed ID: 37540500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-exome sequencing in an individual with severe global developmental delay and intractable epilepsy identifies a novel, de novo GRIN2A mutation.
    Venkateswaran S; Myers KA; Smith AC; Beaulieu CL; Schwartzentruber JA; ; Majewski J; Bulman D; Boycott KM; Dyment DA
    Epilepsia; 2014 Jul; 55(7):e75-9. PubMed ID: 24903190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild orotic aciduria in UMPS heterozygotes: a metabolic finding without clinical consequences.
    Wortmann SB; Chen MA; Colombo R; Pontoglio A; Alhaddad B; Botto LD; Yuzyuk T; Coughlin CR; Descartes M; Grűnewald S; Maranda B; Mills PB; Pitt J; Potente C; Rodenburg R; Kluijtmans LA; Sampath S; Pai EF; Wevers RA; Tiller GE;
    J Inherit Metab Dis; 2017 May; 40(3):423-431. PubMed ID: 28205048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional disruption of pyrimidine nucleoside transporter CNT1 results in a novel inborn error of metabolism with high excretion of uridine and cytidine.
    Wevers RA; Christensen M; Engelke UFH; Geuer S; Coene KLM; Kwast JT; Lund AM; Vissers LELM
    J Inherit Metab Dis; 2019 May; 42(3):494-500. PubMed ID: 30847922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De Novo Mutations in PPP3CA Cause Severe Neurodevelopmental Disease with Seizures.
    Myers CT; Stong N; Mountier EI; Helbig KL; Freytag S; Sullivan JE; Ben Zeev B; Nissenkorn A; Tzadok M; Heimer G; Shinde DN; Rezazadeh A; Regan BM; Oliver KL; Ernst ME; Lippa NC; Mulhern MS; Ren Z; Poduri A; Andrade DM; Bird LM; Bahlo M; Berkovic SF; Lowenstein DH; Scheffer IE; Sadleir LG; Goldstein DB; Mefford HC; Heinzen EL
    Am J Hum Genet; 2017 Oct; 101(4):516-524. PubMed ID: 28942967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early onset developmental delay and epilepsy in pediatric patients with WDR45 variants.
    Chen H; Qian Y; Yu S; Xiao D; Guo X; Wang Q; Hao L; Yan K; Lu Y; Dong X; Zhou W; Wu B; Zhou S; Wang H
    Eur J Med Genet; 2019 Feb; 62(2):149-160. PubMed ID: 29981852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygous truncation mutations of the SMC1A gene cause a severe early onset epilepsy with cluster seizures in females: Detailed phenotyping of 10 new cases.
    Symonds JD; Joss S; Metcalfe KA; Somarathi S; Cruden J; Devlin AM; Donaldson A; DiDonato N; Fitzpatrick D; Kaiser FJ; Lampe AK; Lees MM; McLellan A; Montgomery T; Mundada V; Nairn L; Sarkar A; Schallner J; Pozojevic J; Parenti I; Tan J; Turnpenny P; Whitehouse WP; ; Zuberi SM
    Epilepsia; 2017 Apr; 58(4):565-575. PubMed ID: 28166369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel SMC1A frameshift mutations in children with developmental delay and epilepsy.
    Goldstein JH; Tim-Aroon T; Shieh J; Merrill M; Deeb KK; Zhang S; Bass NE; Bedoyan JK
    Eur J Med Genet; 2015 Oct; 58(10):562-8. PubMed ID: 26386245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors.
    Ng BG; Wolfe LA; Ichikawa M; Markello T; He M; Tifft CJ; Gahl WA; Freeze HH
    Hum Mol Genet; 2015 Jun; 24(11):3050-7. PubMed ID: 25678555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.